个性化文献订阅>期刊> Journal of Medicinal Chemistry
 

A Novel Class of Cycloalkano[b]pyridines as Potent and Orally Active Opioid Receptor-like 1 Antagonists with Minimal Binding Affinity to the hERG K+ Channel.

  作者 Yoshizumi, Takashi;Takahashi, Hirobumi;Miyazoe, Hiroshi;Sugimoto, Yuichi;Tsujita, Tomohiro;Kato, Tetsuya;Ito, Hirokatsu;Kawamoto, Hiroshi;Hirayama, Mioko;Ichikawa, Daisuke;Azuma-Kanoh, Tomoko;Ozaki, Satoshi;Shibata, Yoshihiro;Tani, Takeshi;Chiba, Masato;I  
  选自 期刊  Journal of Medicinal Chemistry;  卷期  2008年51-13;  页码  4021-4029  
  关联知识点  
 

[摘要]A series of compds. based on 7-{[4-(2-methylphenyl)piperidin-1-yl]methyl}-6,7,8,9-tetrahydro-5H-cyclo hepta[b]pyridine-9-ol ((-)-I), a potent and selective opioid receptor-like 1 (ORL1) antagonist, was prepd. and evaluated using structure-activity relationship studies with the aim of removing its affinity to human ether-a-go-go related gene (hERG) K+ channel. From these studies, II was identified as an optimized structure with respect to ORL1 antagonist activity, and affinity to the hERG K+channel. Furthermore, II showed good in vivo antagonism with a wide therapeutic index in regards to adverse cardiovascular effects.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内